Industry description
The investment seeks long-term capital appreciation.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Volume
The average weekly volume growth across all stocks in the AdvisorShares Pure US Cannabis ETF ETF was -55%. For the same stocks of the ETF, the average monthly volume growth was -21% and the average quarterly volume growth was 125%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 53
P/E Growth Rating: 63
Price Growth Rating: 58
SMR Rating: 81
Profit Risk Rating: 97
Seasonality Score: -10 (-100 ... +100)